Skip to content

PAQUES PHARMA

Active Private limited companyfounded 2005active for 21 yearsChaussée de Dinant 11, 5170 ProfondevilleKBO/BCE: BE 0874.668.893

Lifetime

20 annual accounts with figures on one time axis
peak of €315,141 in 2022
€295,378▼ 0.4%
peak of €105,834 in 2022
€45,293▼ 7.5%
peak of €562,303 in 2023
€309,887▼ 44.1%
€487,787▲ 68.3%
peak of 2.3 FTE in 2008
2.1 FTEunchanged
Board1 name since 2005
1 director
Documentsfilings and deeds
28-07-20263 days before the deadline
2025abbreviated format
Dividend €289,833Equity from €554,426 to €309,887Debts from €289,769 to €487,787

Key points

from the 2025 annual accounts

Equity

€309,887 ▼ 44.1%
554,4262024+45,293Profit-289,833Dividend309,8872025

PAQUES PHARMA paid out €289,833 in dividends. That is 640% of the 2025 profit.

Turnover

≈ €1.0m estimated

The accounts state no turnover.

Debts

€487,787 ▲ 68.3%
Other debts
+234,833
Suppliers
+1,822
The rest
-38,637

Debts rose by €198,017 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,386 companies had the same profile as PAQUES PHARMA has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,386 companies, not a prediction for PAQUES PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-06-2005
  • deed of 22-06-2023
  • deed of 22-06-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0874668893
Resignation: (director) Reappointment: (director) · Director discharge: · Name clause: PAQUES PHARMA · General meeting of 20-06-2023 · Gazette deed
Incorporation published on 04-07-2005 · Gazette deed
First establishment Chaussée de Dinant 11, Profondeville
All 29 events

Comparable companies

same main activity, similar in size and age
Company
PAQUES PHARMA Profondeville €797,673 €295,378 38.8% 2.1
PHARMACIE D'ERPENT Namur €699,308 €269,910 42.3% 2.3
PHARMACIE LABAR Dinant €829,475 €231,494 83.4% 2.2
Pharmacie Constandt-Moreau Namur €836,578 €323,961 43.5% 2.4
PHARMACIE GUIOT Gouvy €748,972 €319,997 75.6% 1.9
PHARMACIE GHISBAIN Seraing €762,816 €255,668 87.0% 1.9
PHARMACIE LOUCHEZ-BOUCKAERT Courcelles €894,008 €322,196 44.1% 2.3

These companies have the same main activity as PAQUES PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €699,000 and €894,000, founded between 1999 and 2007.

Official details

Source: KBO
Status
Active since 24-06-2005Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.147.702.6355170 Profondeville, since 13-06-2005
Financial year end
31 December
Peppol
Reachable since 17-02-2025
Company details

Annual accounts 2025

€797,673▼ 5.5%
Employeeson 31-12-2025
3=
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on PAQUES PHARMA

PAQUES PHARMA files the abbreviated format. That format states no turnover. The gross margin fell from €306,760 in 2006 to €295,378 in 2025.

The balance sheet grew most from 2016 to 2017 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PAQUES PHARMA

What is the company number of PAQUES PHARMA?
The company number of PAQUES PHARMA is 0874.668.893. The VAT number is the same number with BE in front: BE 0874.668.893.
Where is PAQUES PHARMA based?
The registered office is at Chaussée de Dinant 11, 5170 Profondeville.Company details
What does PAQUES PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PAQUES PHARMA?
PAQUES PHARMA is a private limited company (BV).
When was PAQUES PHARMA founded?
PAQUES PHARMA was founded on 24-06-2005.
Is PAQUES PHARMA still active?
Yes, PAQUES PHARMA is an active enterprise in the KBO register.
How many employees does PAQUES PHARMA have?
PAQUES PHARMA had an average of 2.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PAQUES PHARMA fall under?
In its 2025 annual accounts, PAQUES PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PAQUES PHARMA?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €295,378 and 42 comparable companies (NACE 477). It probably lies between €800,000 and €1.4m.
Is PAQUES PHARMA profitable?
In financial year 2025, PAQUES PHARMA made a profit of €45,293.
Where can I find the annual accounts of PAQUES PHARMA?
PAQUES PHARMA filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PAQUES PHARMA due?
PAQUES PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.